PMC 6210286
Reported side effects are typically mild and transient: BPC-157: Nausea (rare), mild fatigue in the first week, minor injection site redness TB-500: Mild lethargy during the loading phase, transient head rush immediately after injection, injection site discomfort Combined stack: No documented synergistic toxicity in preclinical or clinical observational data The more significant risks relate to sourcing and administration rather than the peptides themselves
While animal studies extending to 6 weeks have found no concerning signals, humans using the peptide are essentially participating in uncontrolled self-experimentation regarding long-term outcomes
eGFR (estimated glomerular filtration rate): A marker of kidney filtration function
[DOI] [PMC free article] [PubMed] [Google Scholar] Xia L, Ma W, Afrashteh A, Sajadi MA, Fakheri H, Valilo M
Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism